Rite Aid and Heritage Provider Network last month announced a new agreement to bring the Rite Aid Health Alliance program to HPN's chronic and polychronic patients in Southern California.
Anacor Pharmaceuticals announced that the Food and Drug Administration has approved the company's new drug application for Kerydin (tavaborole) topical solution, 5% — an antifungal approved for the topical treatment of onychomycosis of the toenails.
The Pharmacy Quality Alliance on Friday announced several changes to the PQA staff team, effective July 7.
A survey co-released by the Generic Pharmaceutical Association and the National Coalition on Healthcare reveals that 8-in-10 healthcare providers have serious concerns about a proposed Food and Drug Administration rule on generic drug labeling.
With community pharmacies being called on to provide a wider range of services, drug stores across the country are adapting new technologies to ensure that they can meet the evolving needs of their patients and strengthen their role in the nation’s healthcare system.
A wave of new drug introductions and healthcare policy changes has had a significant impact on women’s health care over the past year.
VoicePort on Thursday announced a patent licensing agreement with Walgreens that covers 11 U.S. patents and patent applications owned by Walgreens in the field of prescription alignment.
The Office of National Drug Control Policy released the 2014 National Drug Control Strategy, the Obama Administration’s primary blueprint for drug policy in the United States.
LIU Pharmacy, part of the Arnold and Marie Schwartz College of Pharmacy and Health Sciences, announced that educator and researcher Dr. John Pezzuto has been named dean of the LIU Pharamacy, effective Jan. 1, 2015.
Greenstone, a U.S.-based subsidiary of Pfizer, announced the introduction of doxazosin mesylate tablets.